These findings indicate that bone mineral density screening and pharmacologic intervention should be strongly considered for these high-risk women.
The Miami Cancer Institute is one of the leading organizations in diversity amongst its clinical trials, and chief research officer Scott Lipkin, DPM, CIP, spoke on the present and future of diversity within the organization.
This study assessed whether the accumulative, static, or dynamic method was best suited for determining the familial risk of breast cancer.
The peer-reviewed article provides insights and advice on how to continue providing proper cancer care during the novel coronavirus pandemic.
The study authors found that not only did some professionals view racial and ethnic minorities as less promising study participants, some respondents also reported withholding trial opportunities from minorities based on these perceptions.
Researchers found that regret following allogeneic HSCT was related to disease recurrence, suggesting that social connectedness may serve as a protective factor against later regret.
A nationwide study found that low-dose aspirin was associated with a significantly lower risk of hepatocellular carcinoma and lower liver-related mortality compared to no aspirin use, without a significantly higher risk of gastrointestinal bleeding.
A population-based analysis found that racial and ethnic disparities in childhood central nervous system tumor survival seem to have their roots at least partially in post-diagnosis factors, possibly due to the lack of access to high quality care, leading to poorer overall outcomes.
Previously unrecognized genetic structural variants in childhood leukemias could be used to evaluate the presence of minimal residual disease during chemotherapy and help to determine response to various therapies.
Tracking large numbers of individualized tumor mutations in cell-free DNA improved minimal residual disease detection in breast cancer patients, though the sensitivity is driven by the number of mutations available to track.